Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 2
2001 1
2002 3
2003 1
2006 2
2007 1
2009 3
2010 3
2011 2
2012 3
2013 1
2014 2
2015 2
2016 3
2017 6
2018 3
2019 1
2020 3
2021 5
2022 4
2023 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma.
Meriranta L, Alkodsi A, Pasanen A, Lepistö M, Mapar P, Blaker YN, Jørgensen J, Karjalainen-Lindsberg ML, Fiskvik I, Mikalsen LTG, Autio M, Björkholm M, Jerkeman M, Fluge Ø, Brown P, Jyrkkiö S, Holte H, Pitkänen E, Ellonen P, Leppä S. Meriranta L, et al. Among authors: jyrkkio s. Blood. 2022 Mar 24;139(12):1863-1877. doi: 10.1182/blood.2021012852. Blood. 2022. PMID: 34932792 Free article.
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas.
Arffman M, Meriranta L, Autio M, Holte H, Jørgensen J, Brown P, Jyrkkiö S, Jerkeman M, Drott K, Fluge Ø, Björkholm M, Karjalainen-Lindsberg ML, Beiske K, Pedersen MØ, Leivonen SK, Leppä S. Arffman M, et al. Among authors: jyrkkio s. Med. 2024 Jun 14;5(6):583-602.e5. doi: 10.1016/j.medj.2024.03.007. Epub 2024 Apr 4. Med. 2024. PMID: 38579729 Free article. Clinical Trial.
[Childhood and adolescent cancer was cured--how to support health in adulthood?].
Taskinen M, Vettenranta K, Jokinen E, Lehtinen T, Arola M, Korpela M, Möttönen M, Pesola J, Voutilainen L, Vähäkylä-Aulo A, Mäkinen S, Suontausta-Kyläinpää S, Jyrkkiö S, Lähteenmäki P. Taskinen M, et al. Among authors: jyrkkio s. Duodecim. 2014;130(22-23):2320-30. Duodecim. 2014. PMID: 25558594 Review. Finnish.
Reply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40. Clinical Utility of Trial-estimated Prognostic Models.
Seyednasrollah F, Mahmoudian M, Rautakorpi L, Hirvonen O, Laitinen T, Jyrkkiö S, Elo LL. Seyednasrollah F, et al. Among authors: jyrkkio s. Eur Urol. 2017 Sep;72(3):e70-e71. doi: 10.1016/j.eururo.2017.04.031. Epub 2017 May 9. Eur Urol. 2017. PMID: 28499619 No abstract available.
Harhauttava haimakasvain.
Korkeila E, Jyrkkiö S, Pyrhönen S. Korkeila E, et al. Among authors: jyrkkio s. Duodecim. 2007;123(5):583-5. Duodecim. 2007. PMID: 17441645 Finnish. No abstract available.
47 results